Mechanism of action of coumarin and silver(I)-coumarin complexes against the pathogenic yeast Candida albicans

Toxicology in Vitro

Volumn 21, Issue 5, 2007, Pages 801-808

  Thati, Bhumika ^a,b   Noble, Andy ^b   Rowan, Raymond ^a,c   Creaven, Bernadette S ^b   Walsh, Maureen ^b   McCann, Malachy ^c   Egan, Denise ^b   Kavanagh, Kevin ^a  

^a National Institute for Cellular Biotechnology   (Ireland)

^b DUBLIN INSTITUTE OF TECHNOLOGY   (Ireland)

^c NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

Anti fungal; Candida albicans; Coumarin; Phenanthroline; Silver(I); Yeast

Indexed keywords

4 OXY 3 NITROCOUMARINBIS(1,10 PHENANTHROLINE)SILVER; 6 HYDROXYCOUMARIN 3 CARBOXYLATOSILVER; 7 HYDROXYCOUMARIN 3 CARBOXYLATOSILVER; COUMARIN DERIVATIVE; CYTOCHROME; ERGOSTEROL; SILVER DERIVATIVE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CANDIDA ALBICANS; CELL RESPIRATION; CONTROLLED STUDY; DRUG MECHANISM; LIPOGENESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN SYNTHESIS;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CELL MEMBRANE; COUMARINS; CRYSTALLOGRAPHY, X-RAY; CYTOCHROMES; DNA, FUNGAL; ERGOSTEROL; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON; OXYGEN CONSUMPTION; SILVER COMPOUNDS;

CANDIDA ALBICANS;

EID: 34247146503     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.01.022     Document Type: Article

References (30)

1. Antonella L., Peter H.N., Mario C., Mario D., and Romano D. Molecular targeted treatments for fungal infections: the role of drug combinations. Trends Mol. Med. 9 (2003) 269-276
2. Arthington-Skaggs B.A., David W.W., and Christine J.M. Quantitation of C. albicans ergosterol content improves the correlation between in vitro anti-fungal susceptibilty test results and in vivo outcome after fluconazole. Treatment in a murine model of invasive candidosis. Antimicrob. Agent Chemother. 44 (2000) 2081-2093
3. Coleman D.C., Rinaldi M.G., Haynes K.A., Rex J.H., Summerbell R.C., Anaissie E.J., and Sullivan D.J. Importance of Candida species other than Candida albicans as opportunistic pathogens. Med. Mycol. 36 (1998) 56-65
4. Coyle B., Kavanagh K., McCann M., Devereux M., and Geraghty M. Mode of anti-fungal activity of 1,10-phenanthroline and its Cu(II), Mn(II) and Ag(I) complexes. Biometals 16 (2003) 321-329
5. Coyle B., Kinsella P., McCann M., Devereux M., O'Connor R., Clynes M., and Kavanagh K. Induction of apoptosis in yeast and mammalian cells by exposure to 1,10-phenanthroline metal complexes. Toxicol. In Vitro 18 (2004) 63-70
6. 2O and [Ag(hnc)] (hncH = 4-hydroxy-3-nitro-2H-chromen-2-one). Polyhedron 4 (2005) 949-956
7. Creaven B.S., Egan D.A., Kavanagh K., McCann M., Noble A., Thati B., and Walsh M. Synthesis, anti-microbial and anti-cancer activity of a series of substituted coumarin-3-carboxylatosilver(I) complexes. Inorg. Chim. Acta 359 (2006) 3976-3984
8. Ebbinghaus S.W., Mohler J.L., and Marshall M.E. Renal cell carcinoma: the background, rational and current development of coumarin as a potential therapeutic agent. Coumarins, Biology, Applications and Mode of action (1997), John Wiley, Chichester, England
9. Eshwika A., Coyle B., Devereux M., McCann M., and Kavanagh K. Metal-complexes of 1,10-phenanthroline-5,6-dione alter the susceptibility of the yeast Candida albicans to amphotericin B and miconazole. Biometals 17 (2004) 415-422
10. Ferenczy L., and Maraz A. Transfer of mitochondria by protoplast fusion in Saccharomyces cerevisiae. Nature 268 (1977) 524-525
11. Finn G., Creaven B.S., and Egan D. In vitro cytotoxic potential and mechanism of action of selected coumarins, using human renal cell lines. Cancer Lett. 183 (2002) 61-68
12. Finn G., Creaven B.S., and Egan D. Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase. Biochem. Pharm. 67 (2004) 1779-1788
13. Finn G., Creaven B.S., and Egan D. Effects of Coumarin derivatives on differentiation of melanotic melanoma cells: a functional role for mitogen-activated protein kinases. Eur. J. Pharma Sci. 26 (2005) 16-25
14. Geraghty P., and Kavanagh K. Disruption of mitochondrial function in Candida albicans leads to reduced cellular ergosterol levels and elevated growth in the presence of Amphotericin B. Arch Microbiol. 179 (2003) 295-300
15. Green D., and Kroemer G. The central executioners of apoptosis: caspases or mitochondria?. Trends Cell Biol. 8 (1998) 267-271
16. Irena K., Ilia M., Irina N., Spiro K., and Margarita K. New lanthanide complexes of 4-methyl-7-hydroxy-coumarin and their pharmacological activity. Eur. J. Med. Chem. 36 (2001) 339-347
17. Kawase M., Motohasi N., Sakagami H., Kanamato T., Nakashima H., Fereczy L., Walfard K., Miskolci C., and Molnar J. Antimicrobial activity of trifluromethyl ketones and their synergism with promethazine. Int. J. Antimicrob. Agents 18 (2001) 161-165
18. 5,6 desaturation. FEBS Lett. 400 (1997) 80-82
19. Kontoyiannis D.P., and Lewis R.E. Anti-fungal drug resistance in pathogenic fungi. Lancet 359 (2002) 1135-1143
20. Laurin P., Klich M., Dupis-Hamelin C., Mauvais P., Lassaigne P., Bonnefoy A., and Musicki B. Synthesis and in vitro evaluation of novel highly potent coumarin inhibitors of gyrase B. Bioorg. Med. Chem. Lett. 9 (1999) 2079-2084
21. Lewis R.J., Singh O.M., Skarzynski T., Maxwell A., and Wonacott A.J. The nature of inhibition of DNA gyrase by the coumarins and the cyclothialidines. EMBO J. 15 (1996) 1412-1420
22. 4 (phendio = 1,10-phenanthroline-5,6-dione) and its effects on fungal and mammalian cells. Biometals 17 (2004) 635-645
23. Micheal A.P. Epidemiology of fungal infections: the promise of molecular typing. Clin. Infect Dis. 20 (1995) 1535-1539
24. Parks L.W., and Casey W.M. Physiological implications of sterol biosynthesis in yeast. Ann. Rev. Microbiol. 49 (1995) 95-116
25. Reeves E.P., Murphy T., Daly P., and Kavanagh K. Amphotericin B enhances the synthesis and release of the immunosuppressive agent gliotoxin from the pulmonary pathogen Aspergillus fumigatus. J. Med. Microbiol. 53 (2004) 719-725
26. Thornes R.D. Coumarins, melanoma, and cellular immunity. Protect. Agents Cancer (1983) 43-56
27. Thornes R.D., Lynch G., and Sheehan M.V. Cimetidine and coumarin therapy of melanoma. Lancet II (1982) 328
28. Tiew P., Ioset J.R., Kokpal U., Chavasiri W., and Hostettmam K. Anti-fungal, anti-oxidant and larvicidal activities of compounds isolated from the heart wood of Mansonia gagei. Phytotyher. Res. 17 (2003) 190-193
29. Warnock D. Fungal infections in neutropenia: current problems and chemotherapeutic control. J. Antimicro. Chemother. 41 (1998) 95-105
30. Zaha A.A., and Hazem A. Antimicrobial activity of two novel coumarin derivatives: 3-cyanonaptho[1,2-(e)] pyran-2-one and 3-cyano coumarin. New Microbiol. 25 (2002) 213-222